scholarly article | Q13442814 |
P50 | author | Cisca Wijmenga | Q20196322 |
P2093 | author name string | R A Ophoff | |
R J Sinke | |||
R S Kahn | |||
A F Bardoel | |||
S C Bakker | |||
B J Jungerius | |||
M L C Hoogendoorn | |||
R Van't Slot | |||
P2860 | cites work | cDNA cloning of a third human C2-domain-containing class II phosphoinositide 3-kinase, PI3K-C2gamma, and chromosomal assignment of this gene (PIK3C2G) to 12p12 | Q22008624 |
Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophrenia | Q24670103 | ||
A haplotype map of the human genome | Q24679827 | ||
The genetics of schizophrenia | Q24815806 | ||
The International HapMap Project | Q27860695 | ||
Haploview: analysis and visualization of LD and haplotype maps | Q27860955 | ||
Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies | Q28190066 | ||
Genes for schizophrenia? Recent findings and their pathophysiological implications | Q28207952 | ||
Efficiency and power in genetic association studies | Q28278645 | ||
Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21 | Q28281769 | ||
Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies | Q29614926 | ||
Schizophrenia: genes and environment | Q33842577 | ||
Genomewide linkage scan for schizophrenia susceptibility loci among Ashkenazi Jewish families shows evidence of linkage on chromosome 10q22. | Q33906350 | ||
Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia | Q33941953 | ||
Genomewide linkage scan for bipolar-disorder susceptibility loci among Ashkenazi Jewish families | Q33998507 | ||
Oligodendrocyte dysfunction in schizophrenia and bipolar disorder | Q34246905 | ||
Velo-cardio-facial syndrome: a model for understanding the genetics and pathogenesis of schizophrenia | Q34426266 | ||
Cloning and characterization of a novel class II phosphoinositide 3-kinase containing C2 domain | Q34461363 | ||
The PIP5K2A and RGS4 genes are differentially associated with deficit and non-deficit schizophrenia | Q34616234 | ||
Gene expression profiling with DNA microarrays: advancing our understanding of psychiatric disorders. | Q35014684 | ||
White matter changes in schizophrenia: evidence for myelin-related dysfunction | Q35125866 | ||
The use of microarrays to characterize neuropsychiatric disorders: postmortem studies of substance abuse and schizophrenia | Q35207357 | ||
Screening of PIP5K2A promoter region for mutations in bipolar disorder and schizophrenia | Q38322318 | ||
Brain morphology and schizophrenia. A magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures | Q41102237 | ||
Evidence that the inositol phospholipids are necessary for exocytosis. Loss of inositol phospholipids and inhibition of secretion in permeabilized cells caused by a bacterial phospholipase C and removal of ATP. | Q41882249 | ||
A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder | Q42675472 | ||
Polymorphism screening of PIK4CA: possible candidate gene for chromosome 22q11-linked psychiatric disorders. | Q44259408 | ||
Altered thalamic membrane phospholipids in schizophrenia: a postmortem study | Q44953140 | ||
Control of neurite outgrowth and growth cone motility by phosphatidylinositol-3-kinase | Q46931834 | ||
Genome-wide scan in Portuguese Island families identifies 5q31-5q35 as a susceptibility locus for schizophrenia and psychosis | Q47292298 | ||
Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia | Q47820010 | ||
The role of oligodendrocyte pathology in schizophrenia | Q48267380 | ||
Structural evaluation of the prefrontal cortex in schizophrenia | Q48413878 | ||
Electron microscopy of oligodendroglia in severe mental illness. | Q48772850 | ||
Prosaposin deficiency -- a rarely diagnosed, rapidly progressing, neonatal neurovisceral lipid storage disease. Report of a further patient | Q48862963 | ||
Structural abnormalities in frontal, temporal, and limbic regions and interconnecting white matter tracts in schizophrenic patients with prominent negative symptoms | Q49078641 | ||
Analytical implications of epidemiological concepts of interaction. | Q51173023 | ||
Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. | Q51943076 | ||
Pedigree disequilibrium tests for multilocus haplotypes. | Q52010978 | ||
The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. | Q52042140 | ||
Convergent Evidence for 2′,3′-Cyclic Nucleotide 3′-Phosphodiesterase as a Possible Susceptibility Gene for Schizophrenia | Q57279160 | ||
A controlled study of brain structure in monozygotic twins concordant and discordant for schizophrenia | Q57403363 | ||
Demonstrating stratification in a European American population | Q57418313 | ||
Association between polymorphism of the SNAP29 gene promoter region and schizophrenia | Q57437355 | ||
Genome-wide scan in a nationwide study sample of schizophrenia families in Finland reveals susceptibility loci on chromosomes 2q and 5q | Q58070633 | ||
Structural Brain Abnormalities in Patients With Schizophrenia and Their Healthy Siblings | Q60610031 | ||
An international two–stage genome–wide search for schizophrenia susceptibility genes | Q71794031 | ||
Volumetric measure of the frontal and temporal lobe regions in schizophrenia: relationship to negative symptoms | Q73782419 | ||
Polymorphism in SNAP29 gene promoter region associated with schizophrenia | Q73794712 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | schizophrenia | Q41112 |
P304 | page(s) | 1060-8 | |
P577 | publication date | 2008-11-01 | |
P1433 | published in | Molecular Psychiatry | Q6895973 |
P1476 | title | An association screen of myelin-related genes implicates the chromosome 22q11 PIK4CA gene in schizophrenia | |
P478 | volume | 13 |
Q37620241 | A Case-Control Study of the Association between Polymorphisms in the Fibrinogen Alpha Chain Gene and Schizophrenia. |
Q36966486 | A catalog of hemizygous variation in 127 22q11 deletion patients |
Q33458936 | A deletion and a duplication in distal 22q11.2 deletion syndrome region. Clinical implications and review |
Q34326175 | A gene co-expression network in whole blood of schizophrenia patients is independent of antipsychotic-use and enriched for brain-expressed genes |
Q36440064 | A lesson not learned: allele misassignment |
Q24643934 | An association analysis of murine anxiety genes in humans implicates novel candidate genes for anxiety disorders |
Q34823932 | Association between autism spectrum disorder in individuals with velocardiofacial (22q11.2 deletion) syndrome and PRODH and COMT genotypes |
Q33616258 | Association of GRM3 polymorphism with white matter integrity in schizophrenia |
Q35081418 | Association of the PIK4CA schizophrenia-susceptibility gene in adults with the 22q11.2 deletion syndrome |
Q48332128 | Associations between neurodevelopmental genes, neuroanatomy, and ultra high risk symptoms of psychosis in 22q11.2 deletion syndrome. |
Q36498862 | Atlas-based white matter analysis in individuals with velo-cardio-facial syndrome (22q11.2 deletion syndrome) and unaffected siblings |
Q36955877 | Biomarker investigations related to pathophysiological pathways in schizophrenia and psychosis. |
Q58798394 | Cell Type and Species-specific Patterns in Neuronal and Non-neuronal Methylomes of Human and Chimpanzee Cortices |
Q28308288 | Chromosome 8p as a potential hub for developmental neuropsychiatric disorders: implications for schizophrenia, autism and cancer |
Q35115389 | Cognitive, behavioural and psychiatric phenotype in 22q11.2 deletion syndrome |
Q39017298 | Common developmental genome deprogramming in schizophrenia - Role of Integrative Nuclear FGFR1 Signaling (INFS). |
Q37089619 | Copy number variations and risk for schizophrenia in 22q11.2 deletion syndrome |
Q38885442 | Defective phosphoinositide metabolism in autism |
Q28588322 | Dixdc1 is a critical regulator of DISC1 and embryonic cortical development |
Q36794532 | Expression of the G72/G30 gene in transgenic mice induces behavioral changes |
Q48716339 | FGFR2 is associated with bipolar disorder: a large-scale case-control study of three psychiatric disorders in the Chinese Han population |
Q33634654 | Family-based association study of Neuregulin 1 with psychotic bipolar disorder |
Q37476441 | Fibroblast growth factors in schizophrenia |
Q41501850 | Genetic deletion of fibroblast growth factor 14 recapitulates phenotypic alterations underlying cognitive impairment associated with schizophrenia. |
Q33905809 | Genetic variations of PIP4K2A confer vulnerability to poor antipsychotic response in severely ill schizophrenia patients |
Q37196005 | Genome-wide association analysis with gray matter volume as a quantitative phenotype in first-episode treatment-naïve patients with schizophrenia |
Q34514307 | Genotype-phenotype correlation in 22q11.2 deletion syndrome |
Q50304662 | Identification and molecular characterization of two novel chromosomal deletions associated with autism |
Q102379137 | Identifying neurodevelopmental anomalies of white matter microstructure associated with high risk for psychosis in 22q11.2DS |
Q49874112 | Impairment of social behaviors in Arhgef10 knockout mice |
Q64890460 | In the line-up: deleted genes associated with DiGeorge/22q11.2 deletion syndrome: are they all suspects? |
Q52774602 | Involvement of ARHGEF10, GEF for RhoA, in Rab6/Rab8-mediating membrane traffic. |
Q41918413 | Isolated chromosome 8p23.2‑pter deletion: Novel evidence for developmental delay, intellectual disability, microcephaly and neurobehavioral disorders |
Q37564007 | Linking white and grey matter in schizophrenia: oligodendrocyte and neuron pathology in the prefrontal cortex |
Q38100883 | Mammalian phosphatidylinositol 4-kinases as modulators of membrane trafficking and lipid signaling networks. |
Q34642754 | MicroRNA-382 expression is elevated in the olfactory neuroepithelium of schizophrenia patients |
Q39567009 | Modulation of the FGF14:FGF14 homodimer interaction through short peptide fragments. |
Q27691100 | Molecular mechanisms in 22q11 deletion syndrome |
Q104503393 | Multimodal imaging improves brain age prediction and reveals distinct abnormalities in patients with psychiatric and neurological disorders |
Q36162707 | Network-assisted Causal Gene Detection in Genome-wide Association Studies: An Improved Module Search Algorithm |
Q47261020 | Networks of myelin covariance. |
Q34726454 | Personalized medicine in psychiatry: problems and promises |
Q38051210 | Phosphatidylinositol 4-kinases and PI4P metabolism in the nervous system: roles in psychiatric and neurological diseases. |
Q90049726 | Phosphoinositides: Regulators of Nervous System Function in Health and Disease |
Q33819207 | Potential Value of Genomic Copy Number Variations in Schizophrenia |
Q31155236 | Schizophrenia and 22q11.2 deletion syndrome |
Q37559492 | Searching genetic risk factors for schizophrenia and bipolar disorder: learn from the past and back to the future |
Q34660041 | Serotonin Transporter Promoter Region (5-HTTLPR) Polymorphism Is Not Associated With Paroxetine-Induced Ejaculation Delay in Dutch Men With Lifelong Premature Ejaculation |
Q89999211 | Synaptic and Gene Regulatory Mechanisms in Schizophrenia, Autism, and 22q11.2 Copy Number Variant-Mediated Risk for Neuropsychiatric Disorders |
Q39155841 | The mood stabilizer valproate activates human FGF1 gene promoter through inhibiting HDAC and GSK-3 activities |
Q28756691 | The role of positive selection in determining the molecular cause of species differences in disease |
Q34913157 | Transcriptome alterations of mitochondrial and coagulation function in schizophrenia by cortical sequencing analysis |
Q47442451 | Ulk4 deficiency leads to hypomyelination in mice |
Q50323081 | Vibrator and PI4KIIIα govern neuroblast polarity by anchoring non-muscle myosin II. |
Search more.